• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病的遗传学

Genetics of Behçet's disease.

作者信息

Morton Laura T, Situnayake Deva, Wallace Graham R

机构信息

University of Birmingham, Edgbaston, Birmingham, UK.

出版信息

Curr Opin Rheumatol. 2016 Jan;28(1):39-44. doi: 10.1097/BOR.0000000000000234.

DOI:10.1097/BOR.0000000000000234
PMID:26599381
Abstract

PURPOSE OF REVIEW

This article discusses recent genetic and epigenetic associations involved in the pathogenesis of Behçet's disease.

RECENT FINDINGS

Genetic studies have supported the strong association of human leukocyte antigen-B and Behçet's disease, and high production of tumour necrosis factor and low production of interleukin (IL)-10, which have led to therapy based on controlling these effects. Polymorphisms that affect the response to pathogens (TLR and FUT2) are leading to increased interest in responses to microbiomes. Inflammation in Behçet's disease results in vascular damage and several single nucleotide polymorphisms in chemokine and adhesion molecules may be involved in this process. Increased levels of inflammatory cytokines including IL-1β and IL-17 have been linked to altered expression of microRNAs, miR155, miR21 and miR23b. DNA methylation changes in monocytes and lymphocytes have been described that affect the function of these cells.

SUMMARY

Genetic and epigenetic changes affecting cells and molecules involved in Behçet's disease offer new pathways for research, including cytoskeletal protein function, that will provide new targets for therapy, and potentially address the ethnic differences seen in validation of gene studies.

摘要

综述目的

本文讨论了近期与白塞病发病机制相关的遗传和表观遗传学关联。

最新发现

遗传研究支持人类白细胞抗原-B与白塞病的强关联,以及肿瘤坏死因子的高产生和白细胞介素(IL)-10的低产生,这导致了基于控制这些效应的治疗方法。影响对病原体反应的多态性(TLR和FUT2)引发了人们对微生物群反应的更多关注。白塞病中的炎症会导致血管损伤,趋化因子和黏附分子中的几个单核苷酸多态性可能参与了这一过程。包括IL-1β和IL-17在内的炎症细胞因子水平升高与微小RNA、miR155、miR21和miR23b的表达改变有关。已描述了单核细胞和淋巴细胞中的DNA甲基化变化,这些变化会影响这些细胞的功能。

总结

影响白塞病相关细胞和分子的遗传和表观遗传变化为研究提供了新途径,包括细胞骨架蛋白功能,这将为治疗提供新靶点,并有可能解决基因研究验证中出现的种族差异问题。

相似文献

1
Genetics of Behçet's disease.白塞病的遗传学
Curr Opin Rheumatol. 2016 Jan;28(1):39-44. doi: 10.1097/BOR.0000000000000234.
2
Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.白塞病的遗传学与免疫功能障碍及免疫调节治疗方法
J Immunotoxicol. 2017 Dec;14(1):137-151. doi: 10.1080/1547691X.2017.1346008.
3
Behçet's disease.白塞病
Curr Opin Rheumatol. 2008 Jan;20(1):82-7. doi: 10.1097/BOR.0b013e3282f154d1.
4
Behçet's disease: an update on the pathogenesis.白塞病:发病机制的最新进展
Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S6-12.
5
Immunogenetic studies of Behçet's disease.白塞病的免疫遗传学研究。
Rev Rhum Engl Ed. 1996 Jul-Sep;63(7-8):520-7.
6
Genetic Association of a Gain-of-Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet's Disease.IFNGR1 基因功能获得性多态性与基因间区 LNCAROD/DKK1 与白塞病的遗传关联。
Arthritis Rheumatol. 2021 Jul;73(7):1244-1252. doi: 10.1002/art.41637. Epub 2021 May 18.
7
New perspective on Behçet's disease.白塞病的新视角。
Int Rev Immunol. 1997;14(1):89-96. doi: 10.3109/08830189709116847.
8
Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen.白细胞介素-12B启动子多态性在白塞病易感性中的作用:针对血链球菌抗原的Th1免疫反应的参与。
J Invest Dermatol. 2006 Jul;126(7):1534-40. doi: 10.1038/sj.jid.5700203. Epub 2006 Mar 2.
9
[Recent findings on the genetics of Behçet's disease].[白塞病遗传学的最新研究发现]
Ann Med Interne (Paris). 1999 Oct;150(6):499-503.
10
Genetics of Behçet's disease: lessons learned from genomewide association studies.贝切特病的遗传学研究:全基因组关联研究的启示。
Curr Opin Rheumatol. 2014 Jan;26(1):56-63. doi: 10.1097/BOR.0000000000000003.

引用本文的文献

1
Expression Levels of lncRNA NEAT1, miRNA-21, and IL-17 in a Group of Egyptian Patients with Behçet's Disease: Relation to Disease Manifestations and Activity.一组埃及白塞病患者中长链非编码RNA NEAT1、微小RNA-21和白细胞介素-17的表达水平:与疾病表现和活动的关系
Biologics. 2024 Nov 12;18:327-337. doi: 10.2147/BTT.S493191. eCollection 2024.
2
Genetic testing of Behçet's disease using next-generation sequencing to identify monogenic mimics and HLA-B*51.利用下一代测序技术对贝赫切特病进行基因检测,以识别单基因模仿病和HLA - B*51。
Rheumatology (Oxford). 2024 Dec 1;63(12):3457-3470. doi: 10.1093/rheumatology/kead628.
3
Association of IL-23R and IL-10 variations with Behçet disease: a genetic analysis study.
白细胞介素-23 受体和白细胞介素-10 变异与白塞病的关联:一项遗传分析研究。
Immunol Res. 2024 Apr;72(2):293-298. doi: 10.1007/s12026-023-09433-w. Epub 2023 Nov 13.
4
The proportion of C1q-high and ISG15-high monocytes in the skin of patients with Behçet disease.白塞病患者皮肤中C1q高表达和ISG15高表达单核细胞的比例。
Front Pharmacol. 2023 Mar 7;14:1110741. doi: 10.3389/fphar.2023.1110741. eCollection 2023.
5
Low density neutrophils are increased in patients with Behçet's disease but do not explain differences in neutrophil function.白塞病患者的低密度中性粒细胞增多,但这并不能解释中性粒细胞功能的差异。
J Inflamm (Lond). 2022 Mar 31;19(1):5. doi: 10.1186/s12950-022-00302-1.
6
Critical Role of Gut Microbiota and Epigenetic Factors in the Pathogenesis of Behçet's Disease.肠道微生物群和表观遗传因素在白塞病发病机制中的关键作用
Front Cell Dev Biol. 2021 Oct 5;9:719235. doi: 10.3389/fcell.2021.719235. eCollection 2021.
7
Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.炎症性风湿病中葡萄膜炎的免疫病理生理学和临床影响:最新进展。
Eur J Clin Invest. 2021 Aug;51(8):e13572. doi: 10.1111/eci.13572. Epub 2021 May 5.
8
MicroRNA155 Expression in Different Phenotypes and Genotypes of Behçet's Disease in a Sample of Egyptian Patients.埃及患者样本中白塞病不同表型和基因型中的MicroRNA155表达
Mediterr J Rheumatol. 2020 Sep 30;31(3):337-340. doi: 10.31138/mjr.31.3.337. eCollection 2020 Sep.
9
Deep Sequencing Identified Dysregulated Circulating MicroRNAs in Late Onset Preeclampsia.深度测序鉴定出晚发型子痫前期中失调的循环 microRNAs。
In Vivo. 2020 Sep-Oct;34(5):2317-2324. doi: 10.21873/invivo.12044.
10
Pathophysiology and therapy of systemic vasculitides.系统性血管炎的病理生理学与治疗
EXCLI J. 2020 Jun 18;19:817-854. doi: 10.17179/excli2020-1512. eCollection 2020.